Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo

J. Y. Kim, E. J. Lee, J. Seo, SangHo Oh

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Vitiligo is attributable to loss of functional melanocytes and is the most common acquired depigmenting disorder. Oxidative stress and intense ultraviolet irradiation are known to aggravate this condition. The nonhistone high-mobility group box 1 (HMGB1) DNA-binding protein is a physiological activator of immune responses, cellular proliferation and cell death. Although it is implicated in the pathogenesis of autoimmune diseases and cutaneous disorders, the precise role of HMGB1 in melanocytes has yet to be studied. Objectives: To elucidate the effect of HMGB1 on melanocytic survival and its involvement in the pathogenesis of vitiligo. Methods: Melanocytes were treated with recombinant HMGB1 (rHMGB1). Thereafter, apoptosis-, autophagy- and melanogenesis-related molecules were detected. Ex vivo skin organ culture was performed after rHMGB1 treatment. Also, levels of HMGB1 were examined in blood and skin specimens from patients with vitiligo. Results: In this study, rHMGB1 increased expression of cleaved caspase 3 and decreased melanin production and expression of melanogenesis-related molecules. rHMGB1-induced caspase 3 activation was confirmed through preincubation with a pan-caspase inhibitor. In ex vivo experiments for the confirmation of HMGB1-induced melanocyte apoptosis, melanocyte disappearance and increased caspase 3 activation were observed in rHMGB1-treated skin tissues. In Western blot analysis and enzyme-linked immunosorbent assay, patients with active vitiligo showed significantly higher blood levels of HMGB1 (vs. healthy controls). Also, greater expression of HMGB1 was observed in vitiliginous skin (vs. uninvolved skin). Conclusions: External stimuli (e.g. oxidative stress and ultraviolet irradiation) may trigger HMGB1 release by keratinocytes, thereby perpetuating vitiligo through HMGB1-induced melanocytic apoptosis.

Original languageEnglish
Pages (from-to)1558-1568
Number of pages11
JournalBritish Journal of Dermatology
Volume176
Issue number6
DOIs
Publication statusPublished - 2017 Jun 1

Fingerprint

Vitiligo
Melanocytes
HMGB1 Protein
Skin
Survival
Caspase 3
Apoptosis
Oxidative Stress
Caspase Inhibitors
Organ Culture Techniques
Melanins
Autophagy
DNA-Binding Proteins
Keratinocytes
Autoimmune Diseases
Cell Death
Western Blotting
Enzyme-Linked Immunosorbent Assay
Cell Proliferation

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

@article{898eee043b8a44949d0c5f8062207aac,
title = "Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo",
abstract = "Background: Vitiligo is attributable to loss of functional melanocytes and is the most common acquired depigmenting disorder. Oxidative stress and intense ultraviolet irradiation are known to aggravate this condition. The nonhistone high-mobility group box 1 (HMGB1) DNA-binding protein is a physiological activator of immune responses, cellular proliferation and cell death. Although it is implicated in the pathogenesis of autoimmune diseases and cutaneous disorders, the precise role of HMGB1 in melanocytes has yet to be studied. Objectives: To elucidate the effect of HMGB1 on melanocytic survival and its involvement in the pathogenesis of vitiligo. Methods: Melanocytes were treated with recombinant HMGB1 (rHMGB1). Thereafter, apoptosis-, autophagy- and melanogenesis-related molecules were detected. Ex vivo skin organ culture was performed after rHMGB1 treatment. Also, levels of HMGB1 were examined in blood and skin specimens from patients with vitiligo. Results: In this study, rHMGB1 increased expression of cleaved caspase 3 and decreased melanin production and expression of melanogenesis-related molecules. rHMGB1-induced caspase 3 activation was confirmed through preincubation with a pan-caspase inhibitor. In ex vivo experiments for the confirmation of HMGB1-induced melanocyte apoptosis, melanocyte disappearance and increased caspase 3 activation were observed in rHMGB1-treated skin tissues. In Western blot analysis and enzyme-linked immunosorbent assay, patients with active vitiligo showed significantly higher blood levels of HMGB1 (vs. healthy controls). Also, greater expression of HMGB1 was observed in vitiliginous skin (vs. uninvolved skin). Conclusions: External stimuli (e.g. oxidative stress and ultraviolet irradiation) may trigger HMGB1 release by keratinocytes, thereby perpetuating vitiligo through HMGB1-induced melanocytic apoptosis.",
author = "Kim, {J. Y.} and Lee, {E. J.} and J. Seo and SangHo Oh",
year = "2017",
month = "6",
day = "1",
doi = "10.1111/bjd.15151",
language = "English",
volume = "176",
pages = "1558--1568",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "6",

}

Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo. / Kim, J. Y.; Lee, E. J.; Seo, J.; Oh, SangHo.

In: British Journal of Dermatology, Vol. 176, No. 6, 01.06.2017, p. 1558-1568.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo

AU - Kim, J. Y.

AU - Lee, E. J.

AU - Seo, J.

AU - Oh, SangHo

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Background: Vitiligo is attributable to loss of functional melanocytes and is the most common acquired depigmenting disorder. Oxidative stress and intense ultraviolet irradiation are known to aggravate this condition. The nonhistone high-mobility group box 1 (HMGB1) DNA-binding protein is a physiological activator of immune responses, cellular proliferation and cell death. Although it is implicated in the pathogenesis of autoimmune diseases and cutaneous disorders, the precise role of HMGB1 in melanocytes has yet to be studied. Objectives: To elucidate the effect of HMGB1 on melanocytic survival and its involvement in the pathogenesis of vitiligo. Methods: Melanocytes were treated with recombinant HMGB1 (rHMGB1). Thereafter, apoptosis-, autophagy- and melanogenesis-related molecules were detected. Ex vivo skin organ culture was performed after rHMGB1 treatment. Also, levels of HMGB1 were examined in blood and skin specimens from patients with vitiligo. Results: In this study, rHMGB1 increased expression of cleaved caspase 3 and decreased melanin production and expression of melanogenesis-related molecules. rHMGB1-induced caspase 3 activation was confirmed through preincubation with a pan-caspase inhibitor. In ex vivo experiments for the confirmation of HMGB1-induced melanocyte apoptosis, melanocyte disappearance and increased caspase 3 activation were observed in rHMGB1-treated skin tissues. In Western blot analysis and enzyme-linked immunosorbent assay, patients with active vitiligo showed significantly higher blood levels of HMGB1 (vs. healthy controls). Also, greater expression of HMGB1 was observed in vitiliginous skin (vs. uninvolved skin). Conclusions: External stimuli (e.g. oxidative stress and ultraviolet irradiation) may trigger HMGB1 release by keratinocytes, thereby perpetuating vitiligo through HMGB1-induced melanocytic apoptosis.

AB - Background: Vitiligo is attributable to loss of functional melanocytes and is the most common acquired depigmenting disorder. Oxidative stress and intense ultraviolet irradiation are known to aggravate this condition. The nonhistone high-mobility group box 1 (HMGB1) DNA-binding protein is a physiological activator of immune responses, cellular proliferation and cell death. Although it is implicated in the pathogenesis of autoimmune diseases and cutaneous disorders, the precise role of HMGB1 in melanocytes has yet to be studied. Objectives: To elucidate the effect of HMGB1 on melanocytic survival and its involvement in the pathogenesis of vitiligo. Methods: Melanocytes were treated with recombinant HMGB1 (rHMGB1). Thereafter, apoptosis-, autophagy- and melanogenesis-related molecules were detected. Ex vivo skin organ culture was performed after rHMGB1 treatment. Also, levels of HMGB1 were examined in blood and skin specimens from patients with vitiligo. Results: In this study, rHMGB1 increased expression of cleaved caspase 3 and decreased melanin production and expression of melanogenesis-related molecules. rHMGB1-induced caspase 3 activation was confirmed through preincubation with a pan-caspase inhibitor. In ex vivo experiments for the confirmation of HMGB1-induced melanocyte apoptosis, melanocyte disappearance and increased caspase 3 activation were observed in rHMGB1-treated skin tissues. In Western blot analysis and enzyme-linked immunosorbent assay, patients with active vitiligo showed significantly higher blood levels of HMGB1 (vs. healthy controls). Also, greater expression of HMGB1 was observed in vitiliginous skin (vs. uninvolved skin). Conclusions: External stimuli (e.g. oxidative stress and ultraviolet irradiation) may trigger HMGB1 release by keratinocytes, thereby perpetuating vitiligo through HMGB1-induced melanocytic apoptosis.

UR - http://www.scopus.com/inward/record.url?scp=85017176249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017176249&partnerID=8YFLogxK

U2 - 10.1111/bjd.15151

DO - 10.1111/bjd.15151

M3 - Article

C2 - 27787879

AN - SCOPUS:85017176249

VL - 176

SP - 1558

EP - 1568

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 6

ER -